Effects of Thoracic Erector Spinae Plane Blockade on Acute and Chronic Pain After Video Assisted Thoracoscopic Surgery (VATS)
Thoracic
About this trial
This is an interventional treatment trial for Thoracic focused on measuring Thoracic surgical procedures
Eligibility Criteria
Inclusion Criteria:
- Male and Female participants providing written informed consent,
- ASA grade 1-3,
- aged over 20 and under 80,
- primary lung cancer participants scheduled segmentectomy or lobectomy c MLND,
- undergoing a VATS procedure under General Anaesthesia
Exclusion Criteria:
- Absence of informed written consent,
- chemotherapy before or after surgery,
- pre existing infection at block site,
- severe coagulopathy,
- pre existing neurological deficit,
- previous history of opiate abuse,
- pregnancy,
- pre existing chronic pain condition,
Sites / Locations
- Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Interventional
Control
Under general anaesthesia, ultrasound guided ESP block will perform at the T5 level with 0.375% ropivacaine 20ml. Fentanyl 1 ug/kg will administer at last 30 minutes of surgery for postoperative analgesia. Patient controlled analgesia (PCA) with fentanyl (10 ug/kg) and palonosetron 0.075mg will apply to the all patients. Postoperative pain assessment and opioid consumption will record till the postoperative 48 hours. Pain assessment will record 3 months after surgery.
Fentanyl 1 ug/kg will administer at last 30 minutes of surgery for postoperative analgesia. Patient controlled analgesia (PCA) with fentanyl (10 ug/kg) and palonosetron 0.075mg will apply to the all patients. Postoperative pain assessment and opioid consumption will record till the postoperative 48 hours. Pain assessment will record 3 months after surgery.